28.10.2011 • News

Majority Stake in CU Chemie Uetikon Sold to Barclays Private Equity

Barclays Private Equity (BPE) has acquired a majority shareholding in CU Chemie Uetikon, a fine chemicals company based in Lahr, Germany.  With a shareholding of 90%, BPE will have a controlling interest in the spin-off from the Swiss group CPH Chemie + Papier Holding AG. Together with management, BPE said it will pursue a consistent growth strategy in pharmaceuticals, cosmetics and nutrition industries. The consideration is undisclosed and completion is subject to regulatory approval.

 

Company

CU Chemie Uetikon

Raiffeisenstr. 4
77933 Lahr
Germany

Company contact







Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Leading Transformation
The Path to Sustainable Growth

Leading Transformation

As Executive Vice President of International Chemicals since early 2024, Antje Gerber has been steering Sasol through a pivotal reset—focused on resilience, innovation, and bold sustainability goals.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.